Meet NovAliX at RICT 2024

Meet NovAliX at RICT in Bordeaux, France, from July 3 to 5, 2024. The 58th International Conference on Medicinal Chemistry is organized by The French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT).

The conference will focus on “Interfacing chemical biology and drug discovery” with a range of scientific topics, including 18 plenary lectures and 6 short lectures.

Great speakers from academia such as Prof. Alesso Ciulli from University of Dundee (UK) with his talk on “How PROTAC degraders work: molecular recognition and design principles” are expected.
Prof. Gregory L.Verdine, President of Lifemine Therapeutics (USA), will give the inaugural lecture on “Toward universal druggability”.

The sessions will focus on, to quote only them:

  • RNA binding molecules
  • Breakthoughs in deep learning, Cryo-EM
  • New modalities for drug discovery
  • Recent trends in neurodegenerative diseases drug development
  • Next generation cancer therapeutics
  • First disclosures of clinical candidates and cases studies
  • Enabling technologies

Come and discuss your scientific projects with our NovAliX Business Development and scientific team at our booth no.27 at RICT 2024, in the ‘Palais des Congrès’ in Bordeaux:

Anne de Villeroché, PhD, Associate Director Business Development

Anne Pecquery, Director Business Development, Drug Discovery and Pharmacology

Taouès Temal-Laib, PhD, Senior Research Fellow, Director Drug Discovery

Contact us!